Oxycodone Drugs Market Size to Hit USD 11.53 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Oxycodone Drugs Market

5.1. COVID-19 Landscape: Oxycodone Drugs Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Oxycodone Drugs Market, By Product Type

8.1. Oxycodone Drugs Market Revenue and Volume, by Product Type, 2024-2034

8.1.1 Short-acting

8.1.1.1. Market Revenue and Volume Forecast (2021-2034)

8.1.2. Long acting

8.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 9. Global Oxycodone Drugs Market, By Distribution Channel

9.1. Oxycodone Drugs Market Revenue and Volume, by Distribution Channel, 2024-2034

9.1.1. Hospital Pharmacies

9.1.1.1. Market Revenue and Volume Forecast (2021-2034)

9.1.2. Retail Pharmacies

9.1.2.1. Market Revenue and Volume Forecast (2021-2034)

9.1.3. Online Pharmacies

9.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 10. Global Oxycodone Drugs Market, By March

10.1. Oxycodone Drugs Market Revenue and Volume, by March, 2024-2034

10.1.1. Consumer

10.1.1.1. Market Revenue and Volume Forecast (2021-2034)

10.1.2. Automotive

10.1.2.1. Market Revenue and Volume Forecast (2021-2034)

10.1.3. Industrial

10.1.3.1. Market Revenue and Volume Forecast (2021-2034)

10.1.4. Cheese

10.1.4.1. Market Revenue and Volume Forecast (2021-2034)

10.1.5. Others

10.1.5.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 11. Global Oxycodone Drugs Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.1.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

11.1.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.1.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

11.1.4.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.1.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

11.1.5.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.2.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

11.2.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.2.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

11.2.4.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.2.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

11.2.5.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.2.6.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

11.2.6.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.2.7.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

11.2.7.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.3.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

11.3.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.3.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

11.3.4.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.3.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

11.3.5.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.3.6.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

11.3.6.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.3.7.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

11.3.7.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

11.4.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.4.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

11.4.4.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.4.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

11.4.5.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.4.6.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

11.4.6.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.4.7.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

11.4.7.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

11.5.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.5.4.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

11.5.4.3. Market Revenue and Volume Forecast, by March (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Product Type (2021-2034)

11.5.5.2. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

11.5.5.3. Market Revenue and Volume Forecast, by March (2021-2034)

Chapter 12. Company Profiles

12.1. Teva Pharmaceutical Industries Ltd

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Endo Pharmaceuticals Inc

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Collegium Pharmaceutical Inc

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Mallinckrodt Pharmaceuticals

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Sun Pharmaceutical Industries Ltd

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global oxycodone drugs market size is expected to increase USD 11.53 billion by 2034 from USD 6.33 billion in 2023.

The global oxycodone drugs market will register growth rate of 5.6% between 2024 and 2034.

The major players operating in the oxycodone drugs market are Teva Pharmaceutical Industries Ltd, Endo Pharmaceuticals Inc, Collegium Pharmaceutical Inc, Mallinckrodt Pharmaceuticals, Sun Pharmaceutical Industries Ltd, and Others.

The driving factors of the oxycodone drugs market are the rise in the incidence of chronic pain diseases and increasing frequency of long-term illnesses that need pain management.

North America region will lead the global oxycodone drugs market during the forecast period 2024 to 2034.